Document is current
Any future updates will be listed below
-
Authors
Heumann, Philipp https://orcid.org/0000-0001-6650-6045
Aguado-Barrera, Miguel E. https://orcid.org/0000-0002-7822-6726
Jandu, Harkeran K.
Azria, David
Briers, Erik
Bultijnck, Renée https://orcid.org/0000-0003-4122-2323
Chang-Claude, Jenny
Choudhury, Ananya
Dunning, Alison M. https://orcid.org/0000-0001-6651-7166
Fachal, Laura
Fuentes-Ríos, Olivia
Gómez-Caamaño, Antonio https://orcid.org/0000-0002-9773-4590
Gutiérrez-Enríquez, Sara https://orcid.org/0000-0002-1711-6101
Kaaks, Rudolf https://orcid.org/0000-0003-3751-3929
Kerns, Sarah L.
Lambrecht, Maarten https://orcid.org/0000-0002-8746-2691
Romero, Juan Camilo Rosas
Rosenstein, Barry S.
De Ruysscher, Dirk
Schmidt, Martina E. https://orcid.org/0000-0002-2095-2426
Sperk, Elena https://orcid.org/0000-0002-8771-8124
Stobart, Hilary
Symonds, R. Paul
Veldeman, Liv
Veldwijk, Marlon R. https://orcid.org/0000-0002-6821-3489
Ward, Tim
Webb, Adam https://orcid.org/0000-0002-6699-0479
West, Catharine M. L. https://orcid.org/0000-0002-0839-3449
Rancati, Tiziana https://orcid.org/0000-0002-7849-603X
Rattay, Tim https://orcid.org/0000-0002-2824-4854
Vega, Ana https://orcid.org/0000-0002-7416-5137
,
Avuzzi, Barbara
Calvo-Crespo, Patricia
Carballo, Ana
Cicchetti, Alessandro
Defraene, Gilles
Dominguez-Rios, Isabel
Draghici, Roxana
Fajardo-Paneque, Irene
Fernández-Tajes, Juan
Fonteyne, Valérie
Gabriele, Pietro
Giesche, Ulrich
Haustermans, Karin
Helmbold, Irmgard
Herskind, Carsten
Kancherla, Kiran
Kent, Christopher
Lobato-Busto, Ramón
Morlino, Sara
Ost, Piet
Payne, Debbie
Peleteiro, Paula
Rodriguez-Lage, Belinda
Shearer, Rebecca M.
Sosa-Fajardo, Paloma
Stegmaier, Petra
Stock, Richard
Summersgill, Holly
Taboada-Valladares, Begoña
Torrado-Moya, Laura
Valdagni, Riccardo
Vanneste, Ben
Vasanthan, Subramaniam
Talbot, Christopher J. https://orcid.org/0000-0001-7406-8962
Seibold, Petra https://orcid.org/0000-0001-7360-6335
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 31 March 2026
First Online: 22 April 2026
Competing interests
: AC: BMJ Editor in Chief of BMJ Oncology, 08/2022 to present – Employment. Grant/Research Funding from: Cancer Research UK Research, as PIE: Oct 2021 to March 2028; NIHR Research, as PIE: Dec 2023 to Sept 2030; Prostate Cancer UK Research, as PIE: May 2022 to April 2029; Elekta AB Research, as PIE: Jan 2019 to Jan 2029; Medical Research Council (MRC) Research, as PIE: 2018 ongoing; Astex Pharmaceuticals, Joint Lead applicant: Oct 2021 to Aug 2026; Yorkshire Cancer Research, YCR Research Award, Co-applicant: Aug 2022 to Nov 2030 Honoraria for single events around educational talks for commercial organisations: Astra Zeneca: 2023 October to 2025; Merck: 01/2023 - November 2025. DDR: No financial or non-financial competing interests as defined by Nature Portfolio or other interests that might be perceived to influence the interpretation of the article. AstraZeneca Research grant/ support/ Advisory Board: Institutional financial interests (no personal financial interests) BMS Research grant/ support/ Advisory Board: Institutional financial interests (no personal financial interests) Beigene Research grant/ support/ Advisory Board: Institutional financial interests (no personal financial interests) Philips Research grant/ support/ Advisory Board: Institutional financial interests (no personal financial interests) Olink Research grant/ support/ Advisory Board: Institutional financial interests (no personal financial interests) Eli-Lilly Advisory Board: Institutional financial interests (no personal financial interests) Pfizer Support: Institutional financial interests (no personal financial interests). The remaining authors declare no competing interests.
